About us
Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Our Strategic Road Map defines strategies, standards, and policy frameworks to support responsible global use of genomic and related health data.
Discover how a meeting of 50 leaders in genomics and medicine led to an alliance uniting more than 5,000 individuals and organisations to benefit human health.
GA4GH Inc. is a not-for-profit organisation that supports the global GA4GH community.
The GA4GH Council, consisting of the Executive Committee, Strategic Leadership Committee, and Product Steering Committee, guides our collaborative, globe-spanning alliance.
The Funders Forum brings together organisations that offer both financial support and strategic guidance.
The EDI Advisory Group responds to issues raised in the GA4GH community, finding equitable, inclusive ways to build products that benefit diverse groups.
Distributed across a number of Host Institutions, our staff team supports the mission and operations of GA4GH.
Curious who we are? Meet the people and organisations across six continents who make up GA4GH.
More than 500 organisations connected to genomics — in healthcare, research, patient advocacy, industry, and beyond — have signed onto the mission and vision of GA4GH as Organisational Members.
These core Organisational Members are genomic data initiatives that have committed resources to guide GA4GH work and pilot our products.
This subset of Organisational Members whose networks or infrastructure align with GA4GH priorities has made a long-term commitment to engaging with our community.
Local and national organisations assign experts to spend at least 30% of their time building GA4GH products.
Anyone working in genomics and related fields is invited to participate in our inclusive community by creating and using new products.
Wondering what GA4GH does? Learn how we find and overcome challenges to expanding responsible genomic data use for the benefit of human health.
Study Groups define needs. Participants survey the landscape of the genomics and health community and determine whether GA4GH can help.
Work Streams create products. Community members join together to develop technical standards, policy frameworks, and policy tools that overcome hurdles to international genomic data use.
GIF solves problems. Organisations in the forum pilot GA4GH products in real-world situations. Along the way, they troubleshoot products, suggest updates, and flag additional needs.
NIF finds challenges and opportunities in genomics at a global scale. National programmes meet to share best practices, avoid incompatabilities, and help translate genomics into benefits for human health.
Communities of Interest find challenges and opportunities in areas such as rare disease, cancer, and infectious disease. Participants pinpoint real-world problems that would benefit from broad data use.
Find out what’s happening with up to the minute meeting schedules for the GA4GH community.
See all our products — always free and open-source. Do you work on cloud genomics, data discovery, user access, data security or regulatory policy and ethics? Need to represent genomic, phenotypic, or clinical data? We’ve got a solution for you.
All GA4GH standards, frameworks, and tools follow the Product Development and Approval Process before being officially adopted.
Learn how other organisations have implemented GA4GH products to solve real-world problems.
Help us transform the future of genomic data use! See how GA4GH can benefit you — whether you’re using our products, writing our standards, subscribing to a newsletter, or more.
Help create new global standards and frameworks for responsible genomic data use.
Align your organisation with the GA4GH mission and vision.
Want to advance both your career and responsible genomic data sharing at the same time? See our open leadership opportunities.
Join our international team and help us advance genomic data use for the benefit of human health.
Share your thoughts on all GA4GH products currently open for public comment.
Solve real problems by aligning your organisation with the world’s genomics standards. We offer software dvelopers both customisable and out-of-the-box solutions to help you get started.
Learn more about upcoming GA4GH events. See reports and recordings from our past events.
Speak directly to the global genomics and health community while supporting GA4GH strategy.
Be the first to hear about the latest GA4GH products, upcoming meetings, new initiatives, and more.
Questions? We would love to hear from you.
Read news, stories, and insights from the forefront of genomic and clinical data use.
Attend an upcoming GA4GH event, or view meeting reports from past events.
See new projects, updates, and calls for support from the Work Streams.
Read academic papers coauthored by GA4GH contributors.
Listen to our podcast OmicsXchange, featuring discussions from leaders in the world of genomics, health, and data sharing.
Check out our videos, then subscribe to our YouTube channel for more content.
View the latest GA4GH updates, Genomics and Health News, Implementation Notes, GDPR Briefs, and more.
Discover all things GA4GH: explore our news, events, videos, podcasts, announcements, publications, and newsletters.
30 Sep 2022
The GA4GH 10th Plenary gathered 250 attendees and consisted of 36 speakers and 23 panels and workshops, focusing on the challenges posed by the generation, management, and analysis of large amounts of genomic and clinical data.
Press release courtesy of Bioinformatics Barcelona (BIB).
Barcelona’s science museum CosmoCaixa hosted the Global Alliance for Genomics & Health (GA4GH) 10th Plenary meeting on 22 and 23 September. During these two days, genomics and health experts from all over the world agreed on the importance of promoting a more humane medicine by means of state-of-the-art technology.
The conference gathered 250 attendees and consisted of 36 speakers and 23 panels and workshops, focusing on the challenges posed by the generation, management, and analysis of large amounts of genomic and clinical data. Topics ranged from the relevance of genomics in sequencing and tracing SARS-CoV-2, to the future application of personalised treatments for diabetes or cancer patients.
GA4GH is an international alliance leading the promotion of technical standards and policy frameworks which aim to break down the current barriers to biomedical data sharing, in order to advance research and facilitate implementation. Peter Goodhand, CEO of GA4GH, was very satisfied with the outcome of the first in-person Plenary after the pandemic: “It is great to be back in person, and people have said we couldn’t have chosen a better place: Barcelona has made us very much feel at home.”
Goodhand also highlighted the role of the Catalan capital as a genomic research hub, noting Spain was among the top five contributors to GA4GH’s activities. He thanked Bioinformatics Barcelona (BIB) for making this conference possible. BIB, a non-profit association, comprises 70 public and private institutions dedicated to research in biology and computer science with three common goals: knowledge generation, research advances, and industrial competitiveness.
Dr. Ana Ripoll, President of BIB, shared Goodhand’s enthusiasm: “Hosting this meeting is an opportunity to visualise what is being done worldwide, and learning firsthand the latest advances towards a global and personalised healthcare.” Ripoll trusts that technology will humanise medicine by helping health professionals with decision-making so they can dedicate more time to patients.
The conference ended with a guest star, Dr Soumya Swaminathan, Chief Scientist at the World Health Organization. Swaminathan insisted on the need of implementing genomic research on a global scale, also in low and middle income countries, but always in a responsible way that respects standards and policies such as the ones GA4GH promotes.
San Francisco will take over hosting next year’s GA4GH’s Plenary meeting, with the mission to continue guiding technology towards a healthcare model that really serves people.